S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:EPIX

ESSA Pharma Short Interest Ratio and Short Volume

$27.09
+1.66 (+6.53 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$24.82
Now: $27.09
$27.09
50-Day Range
$12.02
MA: $19.86
$28.65
52-Week Range
$3.00
Now: $27.09
$32.69
Volume202,199 shs
Average Volume467,861 shs
Market Capitalization$868.61 million
P/E RatioN/A
Dividend YieldN/A
Beta1.96

Short Interest

ESSA Pharma (NASDAQ:EPIX) Short Interest Data

Current Short Volume45,600 shares
Previous Short Volume42,100 shares
Change Vs. Previous Month:+8.31%
Dollar Volume Sold Short$883,272.00
Short Interest Ratio / Days to Cover0.0
Last Record DateJanuary, 29 2021
Outstanding Shares32,064,000 shares
Float Size15,060,000 shares
Short Percent of Float0.30%
Today's Trading Volume202,199 shares
Average Trading Volume467,861 shares
Today's Volume Vs. Average-56.78%

Short Interest Over Time


ESSA Pharma (NASDAQ:EPIX) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/29/202145,600 shares $883,272.00 +8.3%0.3%0.2 $19.37
1/15/202142,100 shares $717,805.00 -38.4%0.3%0.2 $17.05
12/31/202015,200 shares $212,192.00 +149.2%0.1%0.1 $13.96
12/15/202015,200 shares $177,384.00 +149.2%0.1%0.1 $11.67
11/30/20206,100 shares $48,800.00 -47.0%0.0%0.1 $8.00
11/15/202011,500 shares $80,500.00 -9.5%0.1%0.1 $7.00
10/30/202012,700 shares $82,169.00 +84.1%0.1%0.1 $6.47
10/15/20206,900 shares $41,055.00 -64.1%0.1%0.1 $5.95
9/30/202019,200 shares $124,224.00 +62.7%0.1%0.1 $6.47
9/15/202011,800 shares $80,830.00 -51.4%0.1%0.1 $6.85
8/31/202024,300 shares $185,166.00 -20.9%0.2%0.2 $7.62
8/14/202030,700 shares $222,575.00 -38.8%0.2%0.3 $7.25
7/31/202050,200 shares $335,336.00 +63.5%0.3%0.6 $6.68
7/15/202030,700 shares $214,593.00 -6.1%0.2%0.7 $6.99
6/30/202032,700 shares $210,588.00 +23.9%0.2%1 $6.44
6/15/202026,400 shares $161,040.00 -1.9%0.2%1 $6.10
5/29/202026,900 shares $162,207.00 -3.6%0.2%1.1 $6.03
5/15/202027,900 shares $145,638.00 +4.1%0.2%1 $5.22
4/30/202026,800 shares $139,628.00 -6.0%0.2%0.8 $5.21
4/15/202028,500 shares $133,950.00 +1.1%0.2%0.9 $4.70
3/31/202028,200 shares $115,338.00 -40.3%0.2%0.8 $4.09
3/13/202047,200 shares $187,856.00 -1.1%0.3%1.2 $3.98
2/28/202047,700 shares $178,875.00 -1.0%0.3%1.4 $3.75
2/14/202048,200 shares $214,972.00 +3.0%0.4%1.2 $4.46
1/31/202046,800 shares $234,000.00 -44.8%0.3%1.3 $5.00

ESSA Pharma (NASDAQ:EPIX) Short Interest FAQ

speech bubbles
speech bubbles











What is ESSA Pharma's current short interest?

Short interest is the volume of ESSA Pharma shares that have been sold short but have not yet been covered or closed out. As of January 29th, investors have sold 45,600 shares of EPIX short. 0.30% of ESSA Pharma's shares are currently sold short. View details.

What is a good short interest percentage for ESSA Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.30% of ESSA Pharma's floating shares are currently sold short.

Is ESSA Pharma's short interest increasing or decreasing?

ESSA Pharma saw a increase in short interest in the month of January. As of January 29th, there was short interest totaling 45,600 shares, an increase of 8.3% from the previous total of 42,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ESSA Pharma's float size?

ESSA Pharma currently has issued a total of 32,064,000 shares. Some of ESSA Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ESSA Pharma currently has a public float of 15,060,000 shares.

How does ESSA Pharma's short interest compare to its competitors?

0.30% of ESSA Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ESSA Pharma: Karuna Therapeutics, Inc. (7.06%), Agios Pharmaceuticals, Inc. (0.00%), MorphoSys AG (0.00%), Amicus Therapeutics, Inc. (0.00%), Pacira BioSciences, Inc. (0.00%), Rocket Pharmaceuticals, Inc. (0.00%), Alkermes plc (0.00%), OPKO Health, Inc. (25.34%), ALX Oncology Holdings Inc. (5.27%), and Corcept Therapeutics Incorporated (10.87%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Aon Plc ($5.34 billion), Charter Communications, Inc. ($5.03 billion), ViacomCBS Inc. ($4.99 billion), DuPont de Nemours, Inc. ($4.72 billion), Analog Devices, Inc. ($4.57 billion), Snap Inc. ($3.87 billion), Moderna, Inc. ($3.58 billion), Futu Holdings Limited ($2.75 billion), Snowflake Inc. ($2.43 billion), and Palantir Technologies Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short ESSA Pharma stock?

Short selling EPIX is an investing strategy that aims to generate trading profit from ESSA Pharma as its price is falling. ESSA Pharma's stock is trading up $1.66 today. To short ESSA Pharma stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that ESSA Pharma will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ESSA Pharma?

A short squeeze for ESSA Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of EPIX, which in turn drives the price of the stock up even further.

How often is ESSA Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EPIX, twice per month. The most recent reporting period available is January, 29 2021.



This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.